BBA
WST icon

Baader Bank Aktiengesellschaft’s West Pharmaceutical WST Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$930K Buy
+2,590
New +$792K 0.07% 195
2025
Q3 		– Sell
-1,769
Closed -$380K – 617
2025
Q2 		$380K Buy
+1,769
New +$378K 0.03% 322
2025
Q1 		– Sell
-757
Closed -$247K – 498
2024
Q4 		$247K Buy
757
+28
+4% +$8.81K 0.02% 300
2024
Q3 		$219K Buy
+729
New +$223K 0.01% 364

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Baader Bank Aktiengesellschaft's WST Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft opened a new position in West Pharmaceutical (WST) in Q2 2026: 2,590 shares worth $930K. The stake represents 0.07% of the portfolio and ranks #195 among its holdings. This is a return to the name: Baader Bank Aktiengesellschaft previously reported a position in WST as recently as Q2 2025.

Baader Bank Aktiengesellschaft first reported a position in WST in Q3 2024 and has held it in 4 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Baader Bank Aktiengesellschaft held 2,590 shares of West Pharmaceutical worth $930K as of Q2 2026.
  • West Pharmaceutical was a new Baader Bank Aktiengesellschaft position in Q2 2026.
  • West Pharmaceutical made up 0.07% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #195 holding.
  • Baader Bank Aktiengesellschaft first reported a position in West Pharmaceutical in Q3 2024 and has held it in 4 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.